We are proud to share that SHIFTBIO was selected to participate and present at the prestigious 2026 KDDF Global Biotech Showcase (GBS) held at the Fairmont Ambassador Seoul!
Among a highly competitive pool of innovators, SHIFTBIO achieved double recognition by being selected for two major exclusive sessions:
1. Closed CNS-IR Session
We had the privilege of pitching our cutting-edge therapeutic strategies to an exclusive group of global investors and biopharma leaders, spotlighting our advancements in targeting complex Central Nervous System (CNS) disorders.
2. Innovation Tiger 2026 FAST TRACK
As a featured presenter, we took the main stage to showcase our proprietary NSM Scaffold: Programmable Targeting & Loading platform. We engaged in a high-intensity pitch and a deep-dive Q&A session with the esteemed 'Tiger Panel'—which included global pharma giants and top-tier VCs.
[Shaping the Future of Drug Delivery]
The event sparked deeply meaningful, high-value discussions with global pioneers who share our vision. The immense interest in our programmable Natural Nanoparticle (NNP) platform reinforces our commitment to overcoming the historical limits of tissue-specific drug delivery.
A huge thank you to the Korea Drug Development Fund (KDDF) for hosting such a phenomenal platform for global partnering.
The future of medicine is programmable, and SHIFTBIO is committed to advancing this future.
We are proud to share that SHIFTBIO was selected to participate and present at the prestigious 2026 KDDF Global Biotech Showcase (GBS) held at the Fairmont Ambassador Seoul!
Among a highly competitive pool of innovators, SHIFTBIO achieved double recognition by being selected for two major exclusive sessions:
1. Closed CNS-IR Session
We had the privilege of pitching our cutting-edge therapeutic strategies to an exclusive group of global investors and biopharma leaders, spotlighting our advancements in targeting complex Central Nervous System (CNS) disorders.
2. Innovation Tiger 2026 FAST TRACK
As a featured presenter, we took the main stage to showcase our proprietary NSM Scaffold: Programmable Targeting & Loading platform. We engaged in a high-intensity pitch and a deep-dive Q&A session with the esteemed 'Tiger Panel'—which included global pharma giants and top-tier VCs.
[Shaping the Future of Drug Delivery]
The event sparked deeply meaningful, high-value discussions with global pioneers who share our vision. The immense interest in our programmable Natural Nanoparticle (NNP) platform reinforces our commitment to overcoming the historical limits of tissue-specific drug delivery.
A huge thank you to the Korea Drug Development Fund (KDDF) for hosting such a phenomenal platform for global partnering.
The future of medicine is programmable, and SHIFTBIO is committed to advancing this future.